James Condulis
Stock Analyst at Stifel
(2.42)
# 2,461
Out of 4,876 analysts
5
Total ratings
50%
Success rate
16.67%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Condulis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NAMS NewAmsterdam Pharma Company | Initiates: Buy | $44 | $18.57 | +136.94% | 1 | Jun 10, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $74 → $108 | $83.25 | +29.73% | 2 | Mar 28, 2025 | |
| CYTK Cytokinetics | Initiates: Buy | $80 | $33.16 | +141.25% | 1 | Jan 22, 2025 | |
| EWTX Edgewise Therapeutics | Initiates: Hold | $30 | $13.17 | +127.79% | 1 | Jan 22, 2025 |
NewAmsterdam Pharma Company
Jun 10, 2025
Initiates: Buy
Price Target: $44
Current: $18.57
Upside: +136.94%
Soleno Therapeutics
Mar 28, 2025
Maintains: Buy
Price Target: $74 → $108
Current: $83.25
Upside: +29.73%
Cytokinetics
Jan 22, 2025
Initiates: Buy
Price Target: $80
Current: $33.16
Upside: +141.25%
Edgewise Therapeutics
Jan 22, 2025
Initiates: Hold
Price Target: $30
Current: $13.17
Upside: +127.79%